Biogen Idec
NASDAQ: BIIB
$275.84
-$4.45 (-1.6%)
Closing price January 15, 2021
Tuesday's midday analyst calls included Peloton Interactive, Biogen, Square and Lockheed Martin.
27 days ago
Last Updated: 27 days ago
The November 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
1 month ago
The November 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
1 month ago
These four top stocks offer investors with a longer time horizon solid value and outstanding entry points. They are outstanding ideas for those looking to leave pricier growth companies but wanting...
2 months ago
Some rather significant changes were made in the Berkshire Hathaway equity portfolio during the third quarter.
2 months ago
Last Updated: 2 months ago
Tuesday's top analyst upgrades and downgrades included AbbVie, Beyond Meat, Biogen, Eli Lilly, Levi Strauss, Nvidia, Pfizer, Plug Power, Raytheon, Square and Wayfair.
2 months ago
Last Updated: 2 months ago
24/7 Wall St. has tracked multiple analyst calls regarding the expected approval or nonapproval of aducanumab as the first viable treatment against Alzheimer's disease.
2 months ago
Monday's top analyst upgrades and downgrades included Albermarle, Biogen, Fisker, General Motors, Livent, Marriott International, Uber Technologies and Yelp.
2 months ago
Last Updated: 2 months ago
Thursday's top analyst upgrades and downgrades included Biogen, Honeywell, Microsoft, Ping Identity, Qualcomm, Verizon Communications and Wendy's.
2 months ago
Last Updated: 2 months ago
Biogen shares rocketed up on Wednesday after briefing documents from the FDA provided evidence of the effectiveness of the firm’s Alzheimer’s disease treatment.
2 months ago
Last Updated: 2 months ago
The October 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
2 months ago
Tuesday's top analyst upgrades and downgrades included Advanced Micro Devices, Amazon.com, Amgen, Biogen, Hasbro, Kinder Morgan, SAP, Spotify and Twitter.
2 months ago
Last Updated: 2 months ago
Biogen reported better than expected third-quarter financial results with disappointing guidance before the markets opened on Wednesday.
2 months ago
The September 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
3 months ago
The September 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
3 months ago
Last Updated: 3 months ago